* GeoVax Labs Inc GOVX.OQ GOVX.O is expected to show no
change
in quarterly revenue when it reports results on May 4.
*
* Refinitiv's mean analyst estimate for GeoVax Labs Inc is
for a
loss of 20 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for GeoVax Labs
Inc
is $5, above its last closing price of $0.61.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.25 -0.20 -0.20 Met 0
Sep. 30 2022 -0.12 -0.12 -0.17 Missed -41.7
Jun. 30 2022 -0.32 -0.18 Beat 43.8
Mar. 31 2022 -0.31 -0.31 -0.34 Missed -9.7
Dec. -0.40
31 2021
Sep. 30 2021 -0.37 -0.37 -0.31 Beat 16.2
Jun. 30 2021 -0.43 -0.43 -0.21 Beat 51.2
This summary was machine generated May 3 at 02:04 GMT. All
figures in US dollars unless otherwise stated